HEXIM1 and carcinoma: Of those, antibodies targeting the proteins orthodenticle homeobox 1 (Otx1) and hexamethylene bisacetamide inducible protein 1 (Hexim1) were of sufficient quality for validation in PyMT carcinoma sections.